Target intelligence / Profile preview

Non-structural protein 4A (Hepatitis C virus) (NS4A)

Target
NS4A
Molecular classification
Viral non-structural protein, Enzyme cofactor, Serine protease complex subunit
01

Overview

Non-structural protein 4A (NS4A) is a small, 54-amino acid transmembrane protein encoded by the Hepatitis C virus (HCV) that acts as an essential cofactor for the NS3 serine protease [2, 3]. The formation of the NS3/4A complex is critical for viral maturation, as it catalyzes the proteolytic cleavage of the HCV polyprotein at four specific sites to generate mature NS3, NS4A, NS4B, NS5A, and NS5B proteins [4, 12]. Beyond its structural and catalytic role, NS4A anchors the protease complex to the endoplasmic reticulum membrane and facilitates the cleavage of host cell adaptor proteins such as MAVS (IPS-1) and TRIF, effectively dismantling the host's innate antiviral interferon response [5, 6]. Because of its absolute requirement for viral replication and immune evasion, the NS3/4A complex is a primary target for direct-acting antivirals (DAAs) [7, 10]. Modern NS3/4A protease inhibitors, such as glecaprevir and voxilaprevir, occupy the substrate-binding groove formed by the complex, leading to high cure rates in chronic hepatitis C patients, though the development of resistance-associated substitutions remains a clinical challenge [4, 8].

Other names
HCV NS4ANS4A cofactorp54 proteinNon-structural protein 4A
02

Mechanism of action

Binding and inhibition of the NS3/4A serine protease complex, preventing the cleavage of the viral polyprotein into functional units and blocking the degradation of host innate immune signaling proteins.

03

Biological functions

Viral replicationViral polyprotein processingImmune response evasionMembrane anchoringAutophagy induction
04

Disease associations

Infection (Hepatitis C)Hepatocellular carcinomaLiver cirrhosisInflammation
05

Safety considerations

Drug-drug interactions (CYP3A4 and OATP1B1/3 inhibition)Hepatotoxicity in patients with advanced liver disease (Child-Pugh B or C)Emergence of viral resistance mutationsRisk of HBV reactivation
06

Interacting drugs

Glecaprevir

8 more in the full profile.

07

Biomarkers

HCV RNA viral loadSustained Virologic Response (SVR)NS3/4A resistance-associated substitutions (RASs)Alanine aminotransferase (ALT)

Beyond the preview

Go deeper on Non-structural protein 4A (Hepatitis C virus) (NS4A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-structural protein 4A (Hepatitis C virus) (NS4A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call